TP53 and cancer: The CWR22Rv-1 cells with overexpression of survivin and inhibition of RhoA protected cancer cells from Cuc IIa to some extent, suggesting that mitotic-related pathways involving survivin (which could be cooperating with p53 and p21 pathway) are potential targets to enhance Cuc IIa's anti-cancer potential.